Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Health Care Reform Legislation Would Expand Access To Pharmacist Patient Care Services
Legislation released June 9 by Health, Education, Labor and Pensions (HELP) Committee Chairman Edward Kennedy (D-MA) would expand access to pharmacist-delivered medication therapy management (MTM) services for patients suffering from chronic diseases.

Salmonella's Sweet Tooth Predicts Its Downfall
For the first time UK scientists have shown what the food poisoning bug Salmonella feeds on to survive as it causes infection: glucose.
News of the day
New Survey Reveals Mums Blame Back Pain On Children And Buggies
Children are a pain in the back!
Oncology

Pharming Receives Agreement On Paediatric Investigation Plan For Rhucin(R) From The EMEA Paediatric Committee

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that the Paediatric Committee (PDCO) of the European Medicines Agency (EMEA) has adopted an opinion agreeing the paediatric investigation plan (PIP) for Rhucin® (recombinant human C1 inhibitor) in the therapeutic area of immunology-rheumatology transplantation. "Agreement of the PIP represents a key milestone in Pharming"s regulatory plans for the September 2009 submission of the Rhucin marketing authorisation application," said Dr. Bruno Giannetti, COO of Pharming. According to the EC Regulation 1901/2006 of 12 December 2006, pharmaceutical companies that submit an application for a marketing authorisation for a medicinal product (MAA) in the EU, have to include an approved PIP as part of the regulatory submission. Pharming Group NV


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009